Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Introducing FlexFactory to Poland, delivered by Cytiva and operated by SyVento Biotech

2BScientific limited announces opening of a new European hub in Germany

2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.

SynbiCITE awarded £3m EPSRC grant to expand engineering biology proof-of-concept programme

SynbiCITE, the U.K.’s National Industrial Translation Centre for Engineering Biology, has been awarded a grant of £3m to expand its Proof-of-Concept (PoC) programme for start-up engineering biology companies.

Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Healthcare Agency Veteran Allison Davis Joins CG Life as Chief Client Officer

CG Life, a leading integrated agency that blends strategy, creative, marketing, digital, and communications with science, has welcomed Allison Davis to the agency’s newly created role of Chief Client Officer.

Ansa Biotechnologies Sets New Standard in Long, Complex DNA

Ansa Biotechnologies just announced that it can deliver its Clonal DNA product in lengths up to 5kb. The longer constructs are made possible due to a new proprietary, sequence-agnostic assembly technology. The complete platform allows Ansa to produce long, complex DNA more accurately and reliably than any other DNA synthesis vendor.

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for DKD. MultiOmic’s CEO Robert Thong will present these findings at the LSX Investival Conference in London on 18th November 2024.

Rousselot and IamFluidics Launch Revolutionary Dissolvable Microcarrier for Scalable Cell Culturing

Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production.

William H Morris, MD MBA, Joins Ambience Healthcare as Chief Medical Officer

AppOmni and Cisco Partner to Extend SaaS Security with End-to-End Zero Trust From Endpoint to the Application

AppOmni, the leader in SaaS security today announced a significant partnership that combines the company’s Zero Trust Posture Management (ZTPM) solution with Cisco’s Security Service Edge (SSE) technology suite to enable zero trust principles at the application layer in Security-as-a-Service (SaaS) applications.

The MAP Group acquires SKC as it continues to expand internationally

UK-based pharma strategic consultancy, The MAP Group has acquired market access and pricing consultancy, SKC Beratungsgesellschaft mbH as it continues to expand internationally.

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

Oxford Nanopore announced a landmark strategic partnership that brings together Genomics England, UK Biobank, and NHS England to enable genomics-based translational research and accelerate the development and adoption of Oxford Nanopore’s ground-breaking genomics technology in the NHS.

Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.

Endor Labs Named to Fortune Cyber 60 for Second Consecutive Year

Endor Labs, the leader in open source software security, has once again been selected to the prestigious Fortune Cyber 60 list, the second consecutive year it has received this recognition.